|
|
||||||||
Ultrasonography |
1 From the Departments of Radiology (D.V.S., S.P.K., S.M.H., M.J.O., E.F.H., S.S., P.R.M.) and Surgery (K.K.T.), Massachusetts General Hospital, White 270, 55 Fruit St, Boston, MA 02114. From the 2001 RSNA scientific assembly. Received June 6, 2003; revision requested July 17; final revision received January 30, 2004; accepted February 17. Address correspondence to D.V.S. (e-mail: dsahani@partners.org).
PURPOSE: To retrospectively compare intraoperative ultrasonography (US) and preoperative magnetic resonance (MR) imaging with contrast material enhancement for the depiction of liver lesions in patients undergoing hepatic resection.
MATERIALS AND METHODS: A radiologist (D.V.S.) and a surgeon (K.K.T.) retrospectively identified 79 patients (36 female and 43 male patients; age range, 1078 years; mean age, 57 years) who had undergone surgical resection for primary liver tumor or metastasis and had also undergone preoperative contrast-enhanced MR imaging within 6 weeks before surgery. MR imaging was performed with a 1.5-T system. Dedicated intraoperative US of the liver was performed or supervised by a gastrointestinal radiologist using a 7.5-MHz linear-array transducer, after adequate hepatic mobilization by the surgeon. Histopathologic evaluation of the 159 resected hepatic lesions served as the reference standard. The lesion distribution included colon cancer metastasis (n = 122), hepatocellular carcinoma (n = 23), cholangiocarcinoma (n = 6), cavernous hemangioma (n = 4), focal nodular hyperplasia (n = 2), hamartoma (n = 1), and metastatic embryonal sarcoma (n = 1).
RESULTS: Of 159 lesions, 138 (86.7%) were identified at both MR imaging and intraoperative US. Twelve additional lesions (7.5%) in 10 patients were detected only at intraoperative US (eight metastases, one hepatocellular carcinoma, one cholangiocarcinoma, one hemangioma, and one biliary hamartoma). Both modalities failed to depict nine lesions (5.6%) (four metastases, four hepatocellular carcinomas, and one cholangiocarcinoma). The sensitivities of MR imaging and intraoperative US for liver lesion depiction were 86.7% and 94.3%, respectively. Surgical management was altered on the basis of the intraoperative US findings in only three of 10 patients (4%).
CONCLUSION: Contrast-enhanced MR imaging is as sensitive as intraoperative US in depicting liver lesions before hepatic resection.
© RSNA, 2004
Index terms: Liver, surgery Liver neoplasms, 76.314, 76.323, 76.33 Liver neoplasms, MR, 76.1214, 76.121412, 761.121416, 761.12143 Liver neoplasms, US, 76.12981 Magnetic resonance (MR), comparative studies, 76.121411, 76.121412, 76.12143 Ultrasound (US), comparative studies, 76.12981 Ultrasound (US), intraoperative, 76.12982
This article has been cited by other articles:
![]() |
G. Torzilli, A. Palmisano, D. Del Fabbro, M. Marconi, M. Donadon, A. Spinelli, P. P. Bianchi, and M. Montorsi Contrast-Enhanced Intraoperative Ultrasonography During Surgery for Hepatocellular Carcinoma in Liver Cirrhosis: Is It Useful or Useless? A Prospective Cohort Study of Our Experience Ann. Surg. Oncol., April 1, 2007; 14(4): 1347 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Minagawa, J. Yamamoto, T. Kosuge, Y. Matsuyama, S.-i. Miyagawa, and M. Makuuchi Simplified Staging System for Predicting the Prognosis of Patients With Resectable Liver Metastasis: Development and Validation Arch Surg, March 1, 2007; 142(3): 269 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Benoist, A. Brouquet, C. Penna, C. Julie, M. El Hajjam, S. Chagnon, E. Mitry, P. Rougier, and B. Nordlinger Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure? J. Clin. Oncol., August 20, 2006; 24(24): 3939 - 3945. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Kruskal and R. A. Kane Intraoperative US of the Liver: Techniques and Clinical Applications. RadioGraphics, July 1, 2006; 26(4): 1067 - 1084. [Abstract] [Full Text] [PDF] |
||||